Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have ADHD and Clinically Significant Deficits in Emotional Control

Wednesday, October 19, 2011

Alain Katic, M.D., Houston, TX

Rakesh Jain, M.D., R/D Clinical Research, Inc., Lake Jackson, TX

Bryan Dirks, M.D., Shire Development Inc., Wayne, PA

Thomas F. Babcock, D.O., Shire Development Inc., Wayne, PA

Brian Scheckner, Pharm.D., Shire Development Inc., Wayne, PA

Ben Adeyi, M.S., Shire Development Inc., Wayne, PA

Cynthia Richards, M.D., Shire Development Inc., Wayne, PA

Robert L. Findling, M.D., Psychiatry, University Hospitals Case Medical Center, Cleveland, OH


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 1.30 Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have ADHD and Clinically Significant Deficits in Emotional Control